1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCsLauren Stopfer, Forest M. White, Alicia D. D’Souza|Immuno-Oncology Technology|2021Cited by 29
Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2Brendan Horton, Stefani Spranger, K. Dane Wittrup et al.|JCI Insight|2023Cited by 25
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analysesAlexander Ling, Patrick Y. Wen, Jennifer Gantchev et al.|Science Translational Medicine|2025Cited by 12
Investigative needle core biopsies for multi-omics in GlioblastomaKenny K.H. Yu, Nathalie Y.R. Agar, Sreyashi Basu et al.|medRxiv|2023Cited by 6
Uncovering the signaling networks of disseminated glioblastoma cells <i>in vivo</i> with INSIGHTRyuhjin Ahn, Forest M. White, Lü Long et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1